Filtrona plc
03 October 2006
SCHEDULE 10
NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Name of company
Filtrona plc
2. Name of shareholder having a major interest
Amvescap plc
3. Please state whether notification indicates that it is in respect of holding of the shareholder named in 2
above or in respect of a non-beneficial interest or in the case of an individual holder if it is a holding of that
person's spouse or children under the age of 18
Non-beneficial interest representing funds under management for clients by subsidiary companies.
4. Name of the registered holder(s) and, if more than one holder, the number of
shares held by each of them
Bank of New York (Brussels) 58,359
JP Morgan Chase 742,996
Vidacos Nominees Limited 25,069,117
Bank of New York 121,352
JP Morgan (Hong Kong) 151,759
Bank of Ireland (Dublin) Nominees Limited 306,603
Mellon Bank, Pittsburgh 258,842
Japan Trustee Services Bank 3,641
State Street Trust & Banking Co (London) 3,003,000
Trust & Custody Services 7,096
Northern Trust Company (London) 444,779
HSBC Nominees 77,280
Trimark 761,000
AIM 2,010,174
5. Number of shares / amount of stock acquired
190,000
6. Percentage of issued class
0.09%
7. Number of shares / amount of stock disposed
N/A
8. Percentage of issued class
N/A
9. Class of security
Ordinary Shares
10. Date of transaction
29 September 2006
11. Date company informed
2 October 2006
12. Total holding following this notification
33,015,998
13. Total percentage holding of issued class following this notification
15.05%
14. Any additional information
N/A
15. Name of contact and telephone number for queries
Patricia Kingdon 01908 359100
Deputy Company Secretary
16. Name and signature of authorised company official responsible for making this notification
Jon Green 01908 359100
Company Secretary and General Counsel
Date of notification
3 October 2006
The FSA does not give any express or implied warranty as to the accuracy of this document or material and does not
accept any liability for error or omission. The FSA is not liable for any damages (including, without limitation,
damages for loss of business or loss of profits) arising in contract, tort or otherwise from the use of or inability to
use this document, or any material contained in it, or from any action or decision taken as a result of using this
document or any such material.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.